Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 592

1.

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.

Härmä V, Virtanen J, Mäkelä R, Happonen A, Mpindi JP, Knuuttila M, Kohonen P, Lötjönen J, Kallioniemi O, Nees M.

PLoS One. 2010 May 3;5(5):e10431. doi: 10.1371/journal.pone.0010431.

3.

Differentiation of prostate epithelial cell cultures by matrigel/ stromal cell glandular reconstruction.

Lang SH, Smith J, Hyde C, Macintosh C, Stower M, Maitland NJ.

In Vitro Cell Dev Biol Anim. 2006 Sep-Oct;42(8-9):273-80.

PMID:
17163777
4.

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.

Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cell Death Dis. 2013 Oct 24;4:e875. doi: 10.1038/cddis.2013.407.

5.

Basal prostate epithelial cells stimulate the migration of prostate cancer cells.

Yu HM, Frank DE, Zhang J, You X, Carter WG, Knudsen BS.

Mol Carcinog. 2004 Oct;41(2):85-97.

PMID:
15378647
6.

The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs.

Chen L, Xiao Z, Meng Y, Zhao Y, Han J, Su G, Chen B, Dai J.

Biomaterials. 2012 Feb;33(5):1437-44. doi: 10.1016/j.biomaterials.2011.10.056. Epub 2011 Nov 10.

PMID:
22078807
7.

PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.

Lim M, Chuong CM, Roy-Burman P.

Horm Cancer. 2011 Oct;2(5):298-309. doi: 10.1007/s12672-011-0084-4.

PMID:
21948155
8.

Early human prostate adenocarcinomas harbor androgen-independent cancer cells.

Fiñones RR, Yeargin J, Lee M, Kaur AP, Cheng C, Sun P, Wu C, Nguyen C, Wang-Rodriguez J, Meyer AN, Baird SM, Donoghue DJ, Haas M.

PLoS One. 2013 Sep 25;8(9):e74438. doi: 10.1371/journal.pone.0074438. eCollection 2013.

9.

Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.

MacManus CF, Pettigrew J, Seaton A, Wilson C, Maxwell PJ, Berlingeri S, Purcell C, McGurk M, Johnston PG, Waugh DJ.

Mol Cancer Res. 2007 Jul;5(7):737-48. Epub 2007 Jul 2.

10.

Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients.

Ghayad SE, Cohen PA.

Recent Pat Anticancer Drug Discov. 2010 Jan;5(1):29-57. Review.

PMID:
19751211
11.
12.
13.

Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells.

Okoh VO, Felty Q, Parkash J, Poppiti R, Roy D.

PLoS One. 2013;8(2):e54206. doi: 10.1371/journal.pone.0054206. Epub 2013 Feb 21.

14.

Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures.

Lang SH, Sharrard RM, Stark M, Villette JM, Maitland NJ.

Br J Cancer. 2001 Aug 17;85(4):590-9.

15.

Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines.

Luca AC, Mersch S, Deenen R, Schmidt S, Messner I, Schäfer KL, Baldus SE, Huckenbeck W, Piekorz RP, Knoefel WT, Krieg A, Stoecklein NH.

PLoS One. 2013;8(3):e59689. doi: 10.1371/journal.pone.0059689. Epub 2013 Mar 26.

16.
17.

Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models.

Härmä V, Knuuttila M, Virtanen J, Mirtti T, Kohonen P, Kovanen P, Happonen A, Kaewphan S, Ahonen I, Kallioniemi O, Grafström R, Lötjönen J, Nees M.

Oncogene. 2012 Apr 19;31(16):2075-89. doi: 10.1038/onc.2011.396. Epub 2011 Sep 26.

18.

Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.

Bühler P, Wolf P, Katzenwadel A, Schultze-Seemann W, Wetterauer U, Freudenberg N, Elsässer-Beile U.

Oncol Rep. 2010 Feb;23(2):465-70.

PMID:
20043108
19.

BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.

Dai Y, Siemann DW.

Mol Cancer Ther. 2010 Jun;9(6):1554-61. doi: 10.1158/1535-7163.MCT-10-0359. Epub 2010 Jun 1.

20.

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C.

Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Review.

PMID:
18718806

Supplemental Content

Support Center